abstract |
The present invention discloses novel antibodies that specifically bind transferrin, such as single domain antibodies (sdAbs), or fragments thereof. Also disclosed are compositions, methods and systems that increase the serum half-life of target proteins utilizing antibodies or fragments that bind to human transferrin. |